Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 14, 2026Current Pharmaceutical Design

Emerging Trends in Targeted Molecular Therapies for Inflammatory BowelDisease: Biologics and Small Molecules

View Full Paper
Ask AI
Bookmark
Share

Authors

PBP BorraPCPhool ChandraARArvind Raghav

Discussion

Loading...

Member takes

Overview

Review highlights advances in targeted molecular therapies for IBD, suggesting improved outcomes and new challenges.

Key Points

  • This review aims to summarize recent advancements in targeted molecular therapies for IBD, focusing on biologics and small molecules.
  • Conducted a literature search across PubMed, Scopus, and Web of Science over the last 7 years.
  • Critically analyzed data on therapeutic mechanisms, efficacy, safety, and cost-effectiveness.
  • Biologic therapies show significant improvement in remission and healing but face challenges like immunogenicity and high costs.
  • Small-molecule drugs offer rapid oral alternatives but have systemic safety concerns.
  • Emerging therapies and novel delivery systems show potential but highlight accessibility issues, especially in low-income regions.

Cite This Study

Borra et al. (2026) studied this question.

synapsesocial.com/papers/6a2e465cb1cc60ccdea8b191https://doi.org/10.2174/0113816128417113260325071230
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Biologic and Targeted Therapies in Inflammatory Bowel Disease: Current Evidence and Future Directions2026
  2. 2Biologics, Small Molecules and More in Inflammatory Bowel Disease: The Present and the Future2024 · 19 citations
  3. 3Emerging Therapies in Inflammatory Bowel Disease: A Comprehensive Review2025 · 35 citations
  4. 4Review of Current Medical and Surgical Therapy for Inflammatory Bowel Disease2026 · 1 citations
  5. 5The Evolving Landscape of Advanced Therapies in Inflammatory Bowel Disease: Current Evidence and Emerging Targets2026 · 2 citations